What a 24% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Reporting from across the Journal that names PolyPeptide Group (Hangzhou) Co., Ltd., together with the correspondence this desk has had with the company about it. The dossier itself — the testing record, the correspondence log, the ordering box and the reader reports — is here. The company sells directly at polypeptidegroup.net, a labelled and nofollowed link the Journal is paid nothing for; read the record before you use it.
Follow the resin, not the catalogue.
Nothing on this page is difficult. It is simply unfamiliar, and unfamiliarity is what makes a weak certificate look like a strong one.
Follow the resin, not the catalogue.
Follow the resin, not the catalogue.
Follow the resin, not the catalogue.
Follow the resin, not the catalogue.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Follow the resin, not the catalogue.
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Reported from the analysis, not from a warning notice.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Follow the resin, not the catalogue.